Abivax S.A. (ABVX) KPIs and segments

ABVXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as AAVXF

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 1/30

$90.20−1.24 (-1.36%)

Close on Nov 12, 2026Market cap $7.08BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Abivax's business

Coming soon

This tab will track the numbers specific to Abivax's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?